Aurobindo Pharma Share Price
Know More₹1,092.30 39.55 (3.76%)
04:01 PM, 5-Mar-2025₹1,093.00 41.25 (3.92%)
03:47 PM, 5-Mar-2025BSE : 524804
NSE : AUROPHARMA
Sector : Health care
ISIN Code : INE406A01037
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 05-Mar-2025 | 10:31 AM IST
| Market Cap (₹ Cr) | 63,998 |
Traded Value (₹ Cr) | 1.86 |
Volume (Shares) | 17,006 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,592.55 |
52-Week High Date | 13-Sep-2024 |
52-Week Low (₹) | 985.00 |
52-Week Low Date | 13-Mar-2024 |
All Time High (₹) | 1,592.55 |
All Time High Date | 13-Sep-2024 |
All Time Low (₹) | 0.56 |
All Time Low Date | 20-Nov-1996 |
Aurobindo Pharma News
Aurobindo Pharma Announcement
Aurobindo Pharma Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 64,039 |
| EPS - TTM (₹) [C] | 60.70 |
| P/E Ratio (X) [C] | 18.01 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 150.00 |
| Latest Dividend Date | 20-Feb-2024 |
| Dividend Yield (%) | 0.41 |
| Book Value Share (₹) [C] | 527.00 |
| P/B Ratio (₹) [C] | 2.07 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| LIC MF Nifty Midcap 100 ETF | 7.52 | 71,036 | 1.27 |
| LIC MF Midcap Fund - Regular (G) | 4.36 | 41,223 | 1.58 |
| LIC MF Midcap Fund - Regular (IDCW) | 4.36 | 41,223 | 1.58 |
| LIC MF Midcap Fund - Direct (G) | 4.36 | 41,223 | 1.58 |
| LIC MF Midcap Fund - Direct (IDCW) | 4.36 | 41,223 | 1.58 |
| LIC MF Healthcare Fund - Regular (G) | 2.06 | 19,418 | 2.68 |
| LIC MF Healthcare Fund - Regular (IDCW) | 2.06 | 19,418 | 2.68 |
| LIC MF Healthcare Fund - Direct (G) | 2.06 | 19,418 | 2.68 |
| LIC MF Healthcare Fund - Direct (IDCW) | 2.06 | 19,418 | 2.68 |
Research Reports
Stock Strength
| Today's Low/High (₹) | 1,050.05 1,104.95 |
| Week Low/High (₹) | 1,031.05 1,110.00 |
| Month Low/High (₹) | 1,031.05 1,220.00 |
| Year Low/High (₹) | 984.30 1,592.00 |
| All time Low/High (₹) | 0.56 1,592.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 1.07% | 1.11% | -1.17% | -0.93% |
| 1 Month | -8.29% | -8.29% | -5.80% | -5.74% |
| 3 Month | -12.12% | -12.11% | -9.83% | -9.60% |
| 6 Month | -28.68% | -28.73% | -10.31% | -11.17% |
| 1 Year | 0.88% | 0.84% | 0.07% | -0.08% |
| 3 Year | 79.03% | 79.37% | 35.70% | 37.50% |
Company Info
Company Information
Vice Chairman & M.D. : Kambam Nityananda Reddy
Whole-time Director : M Madan Mohan Reddy
Non Executive Director : P V Ramprasad Reddy
Independent Director : Savita Mahajan
Independent Director : Girish Paman Vanvari
Non Executive Director : P Sarath Chandra Reddy
Independent Director : Santanu Mukherjee
Independent Director : Deepali Pant Joshi
Chairman & Independent Directo : M R Kumar
Non Executive Director : Satakarni Makkapati
Registered Office: Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet,Hyderabad,Telangana-500038 Ph: 91-40-23736370
FAQs about Aurobindo Pharma Ltd
1. What's the Aurobindo Pharma Ltd share price today?
Aurobindo Pharma Ltd share price was Rs 1,092.30 at 04:01 PM IST on 5th Mar 2025. Aurobindo Pharma Ltd share price was up by 3.76% over the previous closing price of Rs 1,052.75. Aurobindo Pharma Ltd share price trend:
- Last 1 Month: Aurobindo Pharma Ltd share price moved down by 8.29% on BSE
- Last 3 Months: Aurobindo Pharma Ltd share price moved down by 12.12% on BSE
- Last 12 Months: Aurobindo Pharma Ltd share price moved up by 0.88% on BSE
- Last 3 Years: Aurobindo Pharma Ltd price moved up by 79.03% on BSE
2. How can I quickly analyse the performance of the Aurobindo Pharma Ltd stock?
The performance of the Aurobindo Pharma Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 18.01
- Price to book value ratio is 2.07
- Dividend yield of 0.41
- The EPS (trailing 12 months) of the Aurobindo Pharma Ltd stock is Rs 60.70
3. What is the market cap of Aurobindo Pharma Ltd?
Aurobindo Pharma Ltd has a market capitalisation of Rs 63,998 crore.
4. What is Aurobindo Pharma Ltd's 52-week high/low share price?
The Aurobindo Pharma Ltd’s 52-week high share price is Rs 1,592.55 and 52-week low share price is Rs 985.00.
5. Is the Aurobindo Pharma Ltd profitable?
On a consolidated basis, Aurobindo Pharma Ltd reported a profit of Rs 472.05 crore on a total income of Rs 2,970.89 crore for the quarter ended 2024. For the year ended Dec 2024, Aurobindo Pharma Ltd had posted a profit of Rs 845.57 crore on a total income of Rs 8,137.40 crore.
6. Which are Aurobindo Pharma Ltd’s peers in the Health care sector?
Aurobindo Pharma Ltd’s top 5 peers in the Health care sector are Lupin, Zydus Lifesci., Abbott India, Aurobindo Pharma, Alkem Lab, Glaxosmi. Pharma, Glenmark Pharma..
7. Who owns how much in Aurobindo Pharma Ltd?
Key changes to the Aurobindo Pharma Ltd shareholding are as follows:
- Promoter holding in Aurobindo Pharma Ltd has gone down to 51.82 per cent as of Dec 2024 from 51.83 per cent as of Mar 2024.
- Mutual Funds Uti holding in Aurobindo Pharma Ltd has gone down to 17.81 per cent as of Dec 2024 from 17.83 per cent as of Mar 2024.
- Foreign Institutional Investors holding in Aurobindo Pharma Ltd has gone down to 16.29 per cent as of Dec 2024 from 18.02 per cent as of Mar 2024.
- Indian Public holding in Aurobindo Pharma Ltd has gone up to 5.52 per cent as of Dec 2024 from 5.51 per cent as of Mar 2024.
- Insurance Companies holding in Aurobindo Pharma Ltd has gone up to 5.12 per cent as of Dec 2024 from 5.03 per cent as of Mar 2024.
- Other Institutional Investors holding in Aurobindo Pharma Ltd has gone up to 2.28 per cent as of Dec 2024 from 0.41 per cent as of Mar 2024.
- Non Institutional Investors holding in Aurobindo Pharma Ltd has gone down to 1.17 per cent as of Dec 2024 from 1.36 per cent as of Mar 2024.
- Financial Institutions holding in Aurobindo Pharma Ltd has gone up to 0.00 per cent as of Dec 2024 from 0.00 per cent as of Mar 2024.
- Custodians holding in Aurobindo Pharma Ltd has gone up to 0.00 per cent as of Dec 2024 from 0.00 per cent as of Mar 2024.
